BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 30158405)

  • 1. [Current Status and Future Perspectives of the Navigation Surgery in Breast Cancer - The Clinical Utility of Sentinel Lymph Node Biopsy Using ICG].
    Sugie T
    Gan To Kagaku Ryoho; 2018 Aug; 45(8):1139-1143. PubMed ID: 30158405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of indocyanine green and the HyperEye system for detecting sentinel lymph nodes in breast cancer within a population of European patients: a pilot study.
    Coufal O; Fait V
    World J Surg Oncol; 2016 Dec; 14(1):299. PubMed ID: 27905950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
    Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
    World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
    Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
    Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node detection by means of indocyanine green using the Karl Storz VITOM
    Staubach P; Scharl A; Ignatov A; Ortmann O; Inwald EC; Hildebrandt T; Gerken M; Klinkhammer-Schalke M; Scharl S; Papathemelis T
    J Cancer Res Clin Oncol; 2021 Jun; 147(6):1813-1823. PubMed ID: 33230583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sentinel lymph node biopsy using indocyanine green fluorescence in early-stage breast cancer: a meta-analysis.
    Sugie T; Ikeda T; Kawaguchi A; Shimizu A; Toi M
    Int J Clin Oncol; 2017 Feb; 22(1):11-17. PubMed ID: 27864624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Indocyanine Green Fluorescence-Guided Video-Assisted Technique for Sentinel Node Biopsy in Breast Cancer.
    Sorrentino L; Sartani A; Pietropaolo G; Bossi D; Mazzucchelli S; Truffi M; Foschi D; Corsi F
    World J Surg; 2018 Sep; 42(9):2815-2824. PubMed ID: 29404755
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
    Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
    BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Color Fluorescence Navigation System for Intraoperative Transcutaneous Lymphatic Mapping and Resection of Sentinel Lymph Nodes in Breast Cancer: Comparison with the Combination of Gamma Probe Scanning and Visible Dye Methods.
    Hokimoto N; Sugimoto T; Namikawa T; Funakoshi T; Oki T; Ogawa M; Fukuhara H; Inoue K; Sato T; Hanazaki K
    Oncology; 2018; 94(2):99-106. PubMed ID: 29131021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Dual Tracer Indocyanine Green and Radioisotope Versus Gold Standard Sentinel Lymph Node Biopsy in Breast Cancer: The GREENORBLUE Trial.
    Nguyen CL; Zhou M; Easwaralingam N; Seah JL; Azimi F; Mak C; Pulitano C; Warrier S
    Ann Surg Oncol; 2023 Oct; 30(11):6520-6527. PubMed ID: 37402976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Sentinel Lymph Node Biopsy Using Indocyanine Green Fluorescence Plus Radioisotope Method Compared With the Radioisotope-Only Method for Breast Cancer Patients After Neoadjuvant Chemotherapy: A Prospective, Randomized, Open-Label, Single-Center Phase 2 Trial.
    Jung SY; Han JH; Park SJ; Lee EG; Kwak J; Kim SH; Lee MH; Lee ES; Kang HS; Lee KS; Park IH; Sim SH; Jeong HJ; Kwon Y; Lee DE; Kim SK; Lee S
    Ann Surg Oncol; 2019 Aug; 26(8):2409-2416. PubMed ID: 31065958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of discordances in sentinel lymph node reactivity between radioisotope and indocyanine green fluorescence in patients with cN0 breast cancer.
    Jimbo K; Nakadaira U; Watase C; Murata T; Shiino S; Takayama S; Suto A
    Asian J Surg; 2023 Jan; 46(1):277-282. PubMed ID: 35414456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between the indocyanine green fluorescence and blue dye methods for sentinel lymph node biopsy using novel fluorescence image-guided resection equipment in different types of hospitals.
    He K; Chi C; Kou D; Huang W; Wu J; Wang Y; He L; Ye J; Mao Y; Zhang GJ; Wang J; Tian J
    Transl Res; 2016 Dec; 178():74-80. PubMed ID: 27497181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
    Thongvitokomarn S; Polchai N
    Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the Clinical Utility of the ICG Fluorescence Method Compared with the Radioisotope Method for Sentinel Lymph Node Biopsy in Breast Cancer.
    Sugie T; Kinoshita T; Masuda N; Sawada T; Yamauchi A; Kuroi K; Taguchi T; Bando H; Yamashiro H; Lee T; Shinkura N; Kato H; Ikeda T; Yoshimura K; Ueyama H; Toi M
    Ann Surg Oncol; 2016 Jan; 23(1):44-50. PubMed ID: 26275781
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective evaluation of the limitations of near-infrared imaging in detecting axillary sentinel lymph nodes in primary breast cancer.
    Mazouni C; Koual M; De Leeuw F; Conversano A; Leymarie N; Rimareix F; Alkhashnam H; Laplace-Builhé C; Abbaci M
    Breast J; 2018 Nov; 24(6):1006-1009. PubMed ID: 30298539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation study of indocyanine green-rituximab: A new receptor-targeted tracer for sentinel lymph node in breast cancer.
    Cong BB; Sun X; Song XR; Liu YB; Zhao T; Cao XS; Qiu PF; Tian CL; Yu JM; Wang YS
    Oncotarget; 2016 Jul; 7(30):47526-47535. PubMed ID: 27374088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axillary reverse mapping with indocyanine green or isosulfan blue demonstrate similar crossover rates to radiotracer identified sentinel nodes.
    Foster D; Choy N; Porter C; Ahmed S; Wapnir I
    J Surg Oncol; 2018 Mar; 117(3):336-340. PubMed ID: 29228459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy in breast cancer guided by indocyanine green fluorescence.
    Murawa D; Hirche C; Dresel S; Hünerbein M
    Br J Surg; 2009 Nov; 96(11):1289-94. PubMed ID: 19847873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indocyanine green-assisted sentinel lymph node biopsy in melanoma using the "FOVIS" system.
    Göppner D; Nekwasil S; Jellestad A; Sachse A; Schönborn KH; Gollnick H
    J Dtsch Dermatol Ges; 2017 Feb; 15(2):169-178. PubMed ID: 28214320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.